View in EDS HTML Full Text PDF Full Text

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.

Saved in:
Bibliographic Details
Title: Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.
Authors: Ramgi P; Instituto Nacional de Saúde, Maputo, Mozambique., Siribie M; International Vaccine Institute, Seoul, Republic of Korea.; Burkina Institute of Global Health, Ouagadougou, Burkina Faso., Rakotozandrindrainy N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Bule O; Instituto Nacional de Saúde, Maputo, Mozambique., Shrivastava H; International Vaccine Institute, Seoul, Republic of Korea., Chambule L; Instituto Nacional de Saúde, Maputo, Mozambique., Park EL; International Vaccine Institute, Seoul, Republic of Korea., Fernando C; Instituto Nacional de Saúde, Maputo, Mozambique., Boque J; Instituto Nacional de Saúde, Maputo, Mozambique., Macuiana R; Instituto Nacional de Saúde, Maputo, Mozambique., Razafimanantsoa R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Rakotozandrindrainy N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Razafindrabe TJL; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Rakotoarisoa AN; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Raminosoa TM; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Derandrainy HL; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Rakotoson MM; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., de Silva CSS; Instituto Nacional de Saúde, Maputo, Mozambique., Mutombene M; Instituto Nacional de Saúde, Maputo, Mozambique., Massinga C; Instituto Nacional de Saúde, Maputo, Mozambique., Langa JP; Instituto Nacional de Saúde, Maputo, Mozambique., Guarnacci T; International Vaccine Institute, Seoul, Republic of Korea., Kang SSY; International Vaccine Institute, Seoul, Republic of Korea., Jo SK; International Vaccine Institute, Seoul, Republic of Korea., Jeon HJ; International Vaccine Institute, Seoul, Republic of Korea.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Yang Y; China National Biotec Group Company Limited, China., Wang S; China National Biotec Group Company Limited, China., Sugimoto JD; International Vaccine Institute, Seoul, Republic of Korea.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Yang JS; International Vaccine Institute, Seoul, Republic of Korea., Shim BS; International Vaccine Institute, Seoul, Republic of Korea., Binger T; International Vaccine Institute, Seoul, Republic of Korea., Capitine IU; Instituto Nacional de Saúde, Maputo, Mozambique., Aziz AB; International Vaccine Institute, Seoul, Republic of Korea., Park JY; International Vaccine Institute, Seoul, Republic of Korea., Kim DR; International Vaccine Institute, Seoul, Republic of Korea., Rakotozandrindrainy R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Jani IV; Instituto Nacional de Saúde, Maputo, Mozambique., Tadesse BT; International Vaccine Institute, Seoul, Republic of Korea.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Marks F; International Vaccine Institute, Seoul, Republic of Korea.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, China.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Jul 22; Vol. 80 (12 Suppl 2), pp. S37-S46.
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40694514
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ramgi+P%22">Ramgi P</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Siribie+M%22">Siribie M</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Burkina Institute of Global Health, Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Rakotozandrindrainy+N%22">Rakotozandrindrainy N</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Bule+O%22">Bule O</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Shrivastava+H%22">Shrivastava H</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chambule+L%22">Chambule L</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Park+EL%22">Park EL</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Fernando+C%22">Fernando C</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Boque+J%22">Boque J</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Macuiana+R%22">Macuiana R</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Razafimanantsoa+R%22">Razafimanantsoa R</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Rakotozandrindrainy+N%22">Rakotozandrindrainy N</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Razafindrabe+TJL%22">Razafindrabe TJL</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Rakotoarisoa+AN%22">Rakotoarisoa AN</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Raminosoa+TM%22">Raminosoa TM</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Derandrainy+HL%22">Derandrainy HL</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Rakotoson+MM%22">Rakotoson MM</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22de+Silva+CSS%22">de Silva CSS</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Mutombene+M%22">Mutombene M</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Massinga+C%22">Massinga C</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Langa+JP%22">Langa JP</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Guarnacci+T%22">Guarnacci T</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+SSY%22">Kang SSY</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+SK%22">Jo SK</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+HJ%22">Jeon HJ</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Excler+JL%22">Excler JL</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; China National Biotec Group Company Limited, China.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; China National Biotec Group Company Limited, China.<br /><searchLink fieldCode="AU" term="%22Sugimoto+JD%22">Sugimoto JD</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Yang+JS%22">Yang JS</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shim+BS%22">Shim BS</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Binger+T%22">Binger T</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Capitine+IU%22">Capitine IU</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Aziz+AB%22">Aziz AB</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+JY%22">Park JY</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DR%22">Kim DR</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Rakotozandrindrainy+R%22">Rakotozandrindrainy R</searchLink>; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Jani+IV%22">Jani IV</searchLink>; Instituto Nacional de Saúde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Tadesse+BT%22">Tadesse BT</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Marks+F%22">Marks F</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Jul 22; Vol. 80 (12 Suppl 2), pp. S37-S46.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40694514
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciaf130
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: S37
    Titles:
      – TitleFull: Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ramgi P
      – PersonEntity:
          Name:
            NameFull: Siribie M
      – PersonEntity:
          Name:
            NameFull: Rakotozandrindrainy N
      – PersonEntity:
          Name:
            NameFull: Bule O
      – PersonEntity:
          Name:
            NameFull: Shrivastava H
      – PersonEntity:
          Name:
            NameFull: Chambule L
      – PersonEntity:
          Name:
            NameFull: Park EL
      – PersonEntity:
          Name:
            NameFull: Fernando C
      – PersonEntity:
          Name:
            NameFull: Boque J
      – PersonEntity:
          Name:
            NameFull: Macuiana R
      – PersonEntity:
          Name:
            NameFull: Razafimanantsoa R
      – PersonEntity:
          Name:
            NameFull: Rakotozandrindrainy N
      – PersonEntity:
          Name:
            NameFull: Razafindrabe TJL
      – PersonEntity:
          Name:
            NameFull: Rakotoarisoa AN
      – PersonEntity:
          Name:
            NameFull: Raminosoa TM
      – PersonEntity:
          Name:
            NameFull: Derandrainy HL
      – PersonEntity:
          Name:
            NameFull: Rakotoson MM
      – PersonEntity:
          Name:
            NameFull: de Silva CSS
      – PersonEntity:
          Name:
            NameFull: Mutombene M
      – PersonEntity:
          Name:
            NameFull: Massinga C
      – PersonEntity:
          Name:
            NameFull: Langa JP
      – PersonEntity:
          Name:
            NameFull: Guarnacci T
      – PersonEntity:
          Name:
            NameFull: Kang SSY
      – PersonEntity:
          Name:
            NameFull: Jo SK
      – PersonEntity:
          Name:
            NameFull: Jeon HJ
      – PersonEntity:
          Name:
            NameFull: Excler JL
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Sugimoto JD
      – PersonEntity:
          Name:
            NameFull: Yang JS
      – PersonEntity:
          Name:
            NameFull: Shim BS
      – PersonEntity:
          Name:
            NameFull: Binger T
      – PersonEntity:
          Name:
            NameFull: Capitine IU
      – PersonEntity:
          Name:
            NameFull: Aziz AB
      – PersonEntity:
          Name:
            NameFull: Park JY
      – PersonEntity:
          Name:
            NameFull: Kim DR
      – PersonEntity:
          Name:
            NameFull: Rakotozandrindrainy R
      – PersonEntity:
          Name:
            NameFull: Jani IV
      – PersonEntity:
          Name:
            NameFull: Tadesse BT
      – PersonEntity:
          Name:
            NameFull: Marks F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 07
              Text: 2025 Jul 22
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 12 Suppl 2
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1